-Q Tao Researcher Activity Profile

Research Author Detailed Information 

Q Tao Publication Rate By Year

Q Tao has published 2 paper(s) in 2004, 9 paper(s) in 2007, 1 paper(s) in 2008, for a total of 12 research publications in total.

Q Q Tao Author Information

LAST NAME: tao

FIRST NAME: q

INITIALS: Q

AFFILIATION:

Papers

Q Tao's Publication Record

1. [Improvement of the assay for pre-S2 Ag/Ab detection and its application in different patients] Year Published: 2004
Institute of Hepatology, People's Hospital of Beijing Medical University, Beijing 100044.
2. [Variation in hepatitis C virus NS 5b nucleotide sequence and its relationship with interferon treatment] Year Published: 2004
Institute of Hepatology, Beijing Medical University.
3. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Year Published: 2007
Johns Hopkins Singapore, Biopolis, Singapore.
4. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. Year Published: 2007
CRUK Institute for Cancer Research, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK.
5. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. Year Published: 2007
LRF Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
6. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Year Published: 2007
Cancer Epigenetics Laboratory, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, Chinese University of Hong Kong, China.
7. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. Year Published: 2007
CRUK Institute for Cancer Research, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK.
8. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. Year Published: 2007
LRF Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
9. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. Year Published: 2007
LRF Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
10. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Year Published: 2007
Cancer Epigenetics Laboratory, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, Chinese University of Hong Kong, China.
11. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. Year Published: 2007
LRF Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
12. A novel continuous-time neural network for realizing associative memory. Year Published: 2008
Hefei Inst. of Intelligent Machines, Acad. Sinica, Hefei.